REG - Mobeus Inc&Gwth - Interim Management Statement

Mobeus Income & Growth VCTAnnouncement

10/11/2023 13:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231110:nRSJ1304Ta&default-theme=true

RNS Number : 1304T  Mobeus Income & Growth VCT PLC  10 November 2023

MOBEUS INCOME & GROWTH VCT PLC

("the Company")

LEI:  213800HKOSEVWS7YPH79

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement
for the quarter ended 30 September 2023. The statement also includes relevant
financial information between the end of the period and the date of this
statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

                                                                                           At 30 September 2023  At 30 June 2023

                                                                                           (unaudited)           (unaudited)
 Net assets attributable to shareholders                                                   £102.94 million       £100.15 million
 Shares in issue                                                                           165,644,278           156,718,602
 Net asset value (NAV) per share                                                           62.15 pence           60.12 pence
 Cumulative dividends paid                                                                 161.80 pence          161.80 pence
 Cumulative Total return (net asset value basis) per share since inception                 223.95 pence          221.92 pence

 

The NAV per share has increased by 2.03 pence in the quarter (an increase of
3.4% from the NAV per share at 30 June 2023).

 

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.49 million into
Mable Therapy Limited, a digital health platform for speech therapy and
counselling for children and young adults.

 

On 3 August 2023, the Company completed a new investment of £0.48 million
into Branchspace Limited, a digital retailing consultancy and software
provider to the aviation and travel industry.

 

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.41 million was made into
Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.15 million was made into
Orri Limited, an intensive day care provider for adults with eating disorders.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

 

SHARE BUYBACK DURING THE PERIOD

On 26 September 2023, the Company purchased 946,163 of its own ordinary
shares at a price of 57.11 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED DURING THE PERIOD

On 21 September 2023, a second interim dividend of 4.50 pence per share in
respect of the year ending 31 December 2023 was declared and was paid on 8
November 2023 to all Shareholders whose names were on the register on 29
September 2023. Payment of this interim dividend will reduce NAV per share
(shown above) to 57.65 pence and increase cumulative dividends paid to 166.30
pence per share.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period
and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFFMFDSEDSEFF